Telehealth: The Future of Healthcare in a Post-COVID-19 Era

Living in a digital age means that technology is consistently evolving to fit the needs of its users. Especially, as of late and in light of Covid-19, traditional in-person services have transitioned into remote services. Healthcare is no exception. 

Crowded hospitals and limited face-to-face access mean that providers depend more and more on innovative Telehealth solutions to serve their patients.  

So what is Telehealth? 

According to the Health Resources Services Administration, telehealth is the use of electronic information and telecommunications technologies to support long-distance clinical health care. More than that, it involves patient and professional health-related education, public health, and health administration training. 

These technologies include videoconferencing, store-and-forward imaging, streaming media, and remote testing and sample collection. 

Why is Telehealth the future of Healthcare? 

As Telehealth continues to grow, patients will discover that they can receive quality healthcare services from the comfort of their homes. Most Healthcare plans will eventually involve some form of remote assistance. Even critics and naysayers will be forced, over time, to adapt to telehealth practices. 

At Genotox Laboratories, we understand how telehealth can best serve the interests of patients, physicians, and medical professionals alike. NextGenUDT featuring ToxProtect DNA-verified Urine Drug Testing (UDT) the industry’s first no contact, at home drug testing service. On-demand test results are delivered to a clinician’s EMR or web portal. 

It’s vital that remote testing is authentic and accurate. This includes opiates and opioids, antipsychotics, skeletal muscle relaxants, stimulants, cannabinoids, and other illicit drugs.

Knowing an at-home drug test definitively authenticates samples, reveals mislabeling errors, and detects urine sample substitutions is important. Not to mention, it encourages patients down the right path towards sobriety. 

telehealth, genotox laboratories, at-time drug testing, drug-testing kits, remote drug testing

For more information about ToxProtect DNA-verified Urine Drug Testing (UDT) or the future of Telehealth solutions, visit https://genotoxlabs.com/nextgenudt/ . Or get in touch via info@genotoxlabs.com today.


Genotox Laboratories: The Best At-Home Drug Testing Kit for Physicians

The next best alternative to an in-person witness for drug testing is Genotox Laboratories Revolutionary ToxProtect™ DNA-based urine drug test. The absence of in-person connection due to Covid-19 shouldn’t be a reason to abandon the most authentically verified methods of drug testing. 

As physicians, drug tests should be accurate and verifiable. NextGenUDT featuring ToxProtect DNA-verified Urine Drug Testing (UDT) serves the best interests of patients, physicians, and medical professionals alike. 

Knowing an at-home drug test authenticates samples, reveals mislabeling errors, and detects urine sample substitutions, encourages patients down the right path towards sobriety. Here, adding a cheek swab makes the difference in verifying an authentic sample.

While an array of convincing reasons for physicians to take advantage of this revolutionary telehealth technology exist, the following variables highlight why deciding to invest in NextGenUDT featuring ToxProtect DNA-verified Urine Drug Testing (UDT) is a no brainer: 

Benefits:

Next day results: 98% of NextGenUDT drug test results are report in under 32 hours which is shorter than average. Results should be quick and efficent, given the growing problems with drug misuse, abuse, and diversion leading to more serious issues. 

Growing painmed panel: Testing for Non-opioid monitoring is available through ToxProtect DNA-verified Urine Drug Testing (UDT). This includes testing for various opiates and opioids, antipsychotics, skeletal muscle relaxants, stimulants, cannabinoids, and other illicit drugs.

Psych complete panel: ToxProtect DNA-verified Urine Drug Testing (UDT) provides a complete clinical picture and history of a patient’s care.  

Results connect: Understanding more than a simple positive or negative result is important. Not to mention, Gentox’s integration of an easy to access physicians portal.  

Reflexive dilution: ToxProtect DNA-verified Urine Drug Testing (UDT) effectively Quantifies out-of-range values

Get in Touch:

Although UDT’s are a necessary tool for medication and sobriety monitoring, they can challenge the physician-patient relationship, especially when disagreements arise over results. Ideally, the process should unfold in a smooth, accurate, and respectful manner. For more information about ToxProtect DNA-verified Urine Drug Testing (UDT), visit https://genotoxlabs.com/nextgenudt/ or get in touch via info@genotoxlabs.com today.


Genotox Laboratories ToxDirect TRUTH™: The Best No-Contact At-Home Drug Test

Drug testing often has it’s physical and scientific limitations. At times, tests can be expensive, rigorously time-consuming, and inaccurate.

Luckily, in an age of social and physical distancing, Genotox Laboratories have developed a state-of-art turn-key toxicology solution designed for healthcare professionals who:

  1. Need to monitor telemedicine patients remotely.
  2. Need to Drug Test at a Distance during “shelter in place” mandates.
  3. Prefer to eliminate urine and/or oral fluid collections from taking place within their clinic.

TRUTH™ is the industries first no contact, at home drug testing service with on-demand test results delivered to a clinician’s EMR or web portal. This means you receive all the clinical data you need using a no-contact distance testing method.

Beyond that, Genotox TRUTH™ technology utilizes DNA-verified Urine Drug Testing (UDT) that definitively authenticates samples, reveals mislabeling errors, and detecting potential urine sample substitutions.

Combining a one-time cheek swab with the urine collection process utilizes genomic cross-verification to match a urine sample to its donor. This method of testing can detect over 100 controlled substances. ToxProtect also reveals the presence of synthetic or substitute human urine.

For more information on sample collection procedures visit the following instructional videos:

  1. TRUTH™ swab collection instructions
  2. TRUTH™ urine collection instructions

To get started visit MyTruthTest.com, or for more information contact us


COVID-19 Testing In AUSTIN, TEXAS.

Genotox Labs has the capacity to deliver 1,500 COVID-19 tests per day.

We’re proud to launch our COVID-19 molecular testing services!

These services will offer convenient access to the most accurate test available with fast results. Are you trying to safely get back to family, school, or work? We can help.

Genotox Labs has announced the capacity to complete 1,500 COVID-19 tests per day.

“Our experience has shown that people want a test and a time-frame they can trust,” said Matthew McCarty, MD, founder and CEO of Genotox Labs. “We have the testing experience, and the highly efficient purpose-built workflows delivering accelerated turn-around time to ensure you know the truth as soon as possible, rather than waiting up to ten days or more in some cases,” he added.

Please reach out to us at info@genotoxlabs.com

For More Information, visit Genotoxlabs.com

About Genotox Labs

With 27 combined years of experience as a board-certified anesthesiologist and pain medicine physician, Matthew McCarty, MD became aware of the growing need for enhanced medication monitoring and personalized medicine. As a result, he founded Genotox Laboratories in 2012.

After extensive use of toxicology testing in his practice, Dr. McCarty realized that a better screening assay was essential for verifying UDT sample authenticity. Leveraging the power of molecular diagnostic testing, he invented and co-developed ToxProtect, the first patent pending DNA-authenticated urine drug test.

#covidtest#covid19#covid#coronavirus#Austin#Texas#ATX


Urine Drug Testing is the future of addiction medicine

“Urine Drug testing is the technology of addiction medicine, it is vastly underutilized, both in terms of prevention and treatment.” – Robert L. DuPont, MD

The common tampering and falsification efforts to hide true drug test results include: real human urine sample substitution, synthetic urine sample substitution, “pill scraping”, dilution, oxidizer adulteration, and timing of substance use around the drug test schedule.

Urine drug testing solutions exist today that precisely address all of the above.

In what other area of life would we actively choose an inferior solution when the aforementioned solution is critical to achieving the desired outcome?

Remote drug monitoring with Genotox Labs

#substanceusedisorder#drugtesting#behavioralhealth#addictiontreatment#substanceabuse#ASAM#addictionrecovery#Genotoxlaboratories#toxdirect

Learn More At:

https://www.psychcongress.com/article/testing-technology-addiction


ToxDirect™ at home drug testing service powered by Truth™

ToxDirect™ at home drug testing service powered by Truth™ is featured in the news!

Genotox Labs uses DNA for accurate at home drug tests.

“Providers, at different rates, are realizing this [pandemic] isn’t going away tomorrow,” Genotox Laboratories chief operating officer Shawn Lunney tells Addiction Professional.

“If everybody is really interested in having the highest level of resolution and the most accurate drug test, you could see this sticking around and having long-term potential.”

#telehealth#telemedicine#ASAM#addictiontreatment#addictionrecovery#remotepatientmonitoring#remotemonitoring#athomedrugtesting#athomedrugtest#drugtestingathome#remotedrugtesting#addictionprofessional#drugtesting#toxdirect#genotoxlaboratories

Learn More at:

https://www.psychcongress.com/article/remote-drug-screening-gains-acceptance-during-pandemic


COVID-19 vs the U.S. Opioid Crisis

Extent and severity of the US Opioid Crisis vs. Covid-19
Figure 1. County-level data representing the extent and severity of the U.S. Opioid Crisis and the outbreak of COVID-19 in the U.S. as of May 5, 2020. Suboxone prescriber data from the Substance Abuse and Mental Health Services Administration; COVID-19 case data from The New York Times, based on reports from state and local health agencies.

Currently, the outbreak of SARS-CoV-2019 has infected almost 4 million people worldwide and killed nearly 270,000 (including more than 73,000 in the U.S. alone). The global pandemic has hit the US hard and to make matters worse, is overlaid on the existing opioid U.S. epidemic which claimed an average of over 69,000 lives per year in 2017 and 2018
(CDC) . The nature of COVID-19 and the response to it have placed patients legitimately seeking opioid therapy treatment and those with opioid use disorder at increased risks for suffering the worst effects of opioid misuse. “Two great epidemics of our generation are intersecting in ways that are additively deadly” according to Peter Grinspoon, MD (Harvard Health).

COVID-19: The Catalyst Event to Largescale Telehealth Utilization and Adoption
COVID-19 will “forever change the way consumers seek and receive healthcare. While the pandemic will prove the value of virtual care in a crisis, it will also demonstrate the effectiveness of ongoing chronic care management. This moment will have a lasting effect on the adoption of virtual care and accelerate the shift from in-person care to virtual first engagement for multiple conditions and use cases.” (Arielle Trzcinski, Forrester). Amidst the pandemic, U.S. Telehealth visits are on pace to top 1 billion by the end of 2020, which would be a 25-fold increase over the 2019 number

Paradigm Shift to Telehealth
“Stakeholders generally agree that telehealth can bring
medical care into communities with limited access to
medical providers, reduce wait times for patients, and
be more convenient than traveling to a provider’s office
in both rural and urban areas. It appears telehealth
could play an important role in achieving goals
associated with value-based models by providing
clinically indicated, high quality, “anytime, anywhere”
care.” (Information on Medicare Telehealth, CMS 2018).
With cost-saving benefits and more flexibility for
patients and providers, healthcare companies have good
reason to invest in telehealth. Patients are starting to get
onboard with these programs as well. The number of
global telehealth patients continue to rise year after
year, reaching over 7 million in 2018. A new report
shows that 74% of U.S. consumers would be open to
using telemedicine services and 76% prioritize having
access to care over the need for human interaction with
care providers

Number of Telehealth Visits in The U.S.
The Number of Telehealth visits in 2020 is projected to
spike to over 1 billion based on data gathered in April and May
(Source Forrester Analytics). Telehealth visits in 2019 were
estimated to be 36 million.

Drug Testing is the Technology of Addiction Medicine, it is vastly underutilized, both in terms of prevention and treatment. – Robert Dupont, M.D. The mass adoption of Telehealth is establishing a new norm of patient-centric healthcare delivery. As an addiction treatment and behavioral healthcare providers are pushed to adapt to telehealth patient-centric delivery models, Urine Drug Testing at a Distance will become a vital diagnostic to monitor patients. Introducing Truth™ by Genotox Laboratories. The New Gold Standard of Urine Drug Testing. Truth™ is the only At Home Urine Drug Testing solution utilizing DNA-authentication technology to ensure the identity and integrity of urine samples.

• Conveniently & Safely performed at home
• Authenticates the sample to the donor
• Identifies real human urine and synthetic urine sample substitution
• Identifies pill scraping, dilution, and oxidizer adulteration
• Eliminates the timing of substance use around the urine drug test schedule by randomizing the test schedule
• Tests 110 drugs of abuse, medications, and metabolites
• Detection windows of 3-7 days or longer for certain substances
• Result within 48 hours
• Easy logistics and fulfillment – testing kits sent directly to the patient

ToxDirect greatly enhances drug testing capabilities and eliminates one of the biggest challenges of date, and timing of the drug test
“The ToxDirect™ service greatly enhances drug testing
capabilities and eliminates one of the biggest challenges to
date, the timing of the drug test.”
“With ToxDirect™ we can ensure an excellent level of
accountability compared to any other drug testing solution.”
“Every compliant drug test produces rewards for all
involved.

The COVID-19 Pandemic and Drug Testing

Why Drug Testing at Home May be the New Norm

The COVID-19 Pandemic has created a new “normal” for most of us. For healthcare system stakeholders, the panic resulted in a reactive adoption of telemedicine tools to bridge the gap of no contact, distance care.

As governments loosen shelter in place restrictions and businesses re-open, are we assuming that we will snap back to the old way of healthcare delivery? Is it safe to assume that 100% of patients will return to clinics to receive care? A March 2020 survey by Sage Growth Partners revealed that 36% of patients would switch their care provider in order to have access to virtual care. Is the new “normal” a hybrid of in person + remote care?

It’s evident that the consumerism of healthcare will be a powerful driving force behind the emergence of telemedicine as a standard of care.

Innovative telemedicine tools are readily available. Are you proactive or reactive?

“Be a creator of circumstances rather than a creature of circumstances. Be proactive rather than reactive.” – Brian Tracy

Remote drug monitoring with Genotox Labs

LEARN MORE HERE:


Drug Testing at Home and The Opioid Crisis

At Home Drug Testing and The Future of Telemedicine

“Before the first COVID-19 case in the United States, a different epidemic—the opioid crisis—was taking the lives of 130 Americans per day. Although the pandemic threatens everyone, it is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery.”

According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults (aged 12 and older) battled a substance use disorder in 2017.

Could the relative risk of patients with substance use disorder who are not receiving the standard of care intersect with the relative risk of COVID-19?

LEARN MORE ABOUT AT HOME DRUG TESTING BY CONTACTING US: https://genotoxlabs.com/contact-us/

No Contact Drug Testing

ABOUT GENOTOX LABS:

At Genotox Laboratories, we’re devoted to providing healthcare professionals with accurate, dependable, and actionable toxicology and pharmacogenetics services. We serve pain physicians, family practices, internal medicine, psychiatrists, addiction specialists, OB/GYN, and recovery centers.

With 27 combined years of experience as a board-certified anesthesiologist and pain medicine physician, Matthew McCarty, MD became aware of the growing need for enhanced medication monitoring and personalized medicine. As a result, he founded Genotox Laboratories in 2012.

After extensive use of toxicology testing in his practice, Dr. McCarty realized that a better screening assay was essential for verifying UDT sample authenticity. Leveraging the power of molecular diagnostic testing, he invented and co-developed ToxProtect, the first patent pending DNA-authenticated urine drug test.

TAGS: Remote Urine Test, Drug Test, No Contact Drug Test, ToxDirect

https://www.npr.org/sections/health-shots/2020/03/27/820806440/opioid-addiction-is-a-disease-of-isolation-so-pandemic-puts-recovery-at-risk?



Remote Drug Testing and Telemedicine

Why Remote Drug Testing Saves Lives

2018: “The low rates of telehealth visits for substance use disorder that we found represent a missed opportunity to get people the help they need, especially in the context of the ongoing opioid epidemic,” said study author Haiden Huskamp, professor of health care policy at Harvard Medical School.

“…barriers include regulatory and reimbursement hurdles.” (Health Affairs 2018)

2019: The Centers for Medicare & Medicaid Services proposed three new billing codes to go into effect January 1, 2020 to help combat the opioid epidemic. These codes were established to help improve access to opioid addiction treatment through telemedicine encounters.

2020: COVID-19 Pandemic produces critical need for telehealth services. U.S. government lifts most of the existing telehealth restrictions.

Truth Drug Testing at Home
No Contact Drug Testing

Many companies have been following along with the telehealth evolution for years and have developed tools precisely for these times of transition.

TRUTH™ is industry’s first no contact, at home drug testing service with on-demand test results delivered to a clinician’s EMR or web portal. 100% of the clinical data you need using no contact, distance testing.

TRUTH™ is a turn-key toxicology solution designed for healthcare professionals who:

  1. Need to monitor telemedicine patients remotely
  2. Need to Drug Test at a Distance during “shelter in place” mandates
  3. Prefer to eliminate urine and/or oral fluid collections from taking place within their clinic

Learn More Here About TRUTH™ Here:

TAGS: At Home Drug Testing, Drug Test, Remote Drug Testing, Telemedicine, No Contact Drug Testing

https://www.sciencedaily.com/releases/2018/12/181204155155.htm